장마감
Log in Sign up
SBIO
SBIO
ALPS Medical Breakthroughs ETF
7월 28일 4:00 PM ET (한국 7/29 05:00)
$63.52
-0.96 ▼ -1.49%
🌙 7월 28일 7:34 PM ET (한국 7/29 08:34)
$63.52
+0.00 +0.00%

SBIO ETF is analyzed across 10 metrics including expense ratio, holdings, sector allocation, dividends, RSI, and MACD.

시황 · 실적발표 · 매수매도 신호, 가장 먼저 받아보세요 🔔 구독
Total Expense Ratio
0.5%
Annual operating cost
Net Assets (AUM)
$204M
약 2800억원
Holdings
107 items
Dividend Yield
-
Management Style
Passive
Category US Equities - Industry SectorAsset Type Equities (Stocks)Return% 1Y 93.99%Total Holdings 107Perf Week -2.25%
ETF Type US EquitiesActive/Passive PassiveReturn% 3Y 27.95%AUM $204MPerf Month 0.43%
Expense 0.5%NAV $64.38Return% 5Y 7.94%52W High -8.39%Perf Quarter 17.07%
Dividend TTM -Div Gr. 3/5Y -Return% 10Y 11.42%52W Low 96.35%Perf Half Y 20.94%
Flows% 1M 9.86%Flows% YTD 25.1%Return% SI 9.37%Volatility(W/M) 1.96% 2.78%Perf YTD 24.01%
SMA20 -2.55%SMA50 8.27%SMA200 21.44%RSI (14) 52.38Beta 0.75
IPO 2014/12/31Prev Close $64.48Perf Year 91.77%Avg Volume 0.04MPrice $63.52

📊 ALPS Medical Breakthroughs ETF (SBIO) Investment Analysis

ETF Overview

ALPS Medical Breakthroughs ETF · US Equities - Industry Sector

헬스케어 섹터 — 헬스케어 섹터 ETF (제약·바이오·의료기기)
2014년 상장, 12년 운영 중.

ALPS Medical Breakthroughs ETF는 수수료 및 비용 차감 전 기준으로 S-Network Medical Breakthroughs 지수의 성과를 추종하고자 합니다. 미국 FDA 임상 2상 또는 3상 단계의 치료제를 보유한 시가총액 규모가 작은 생공학 기업들의 주식에 자산의 최소 80%를 투자하는 패시브 운용 펀드입니다.

📘 SBIO ETF 자세히 알아보기 →
U.S.equityhealthcarebiotechnology
규모
$204M 약 2800억원
운용사
ALPS
운용 방식
패시브 (지수 추종)
상장일
2014년

Cost Efficiency

Annual Expense Ratio · Category Rank · Long-Term Cost Impact

Average expense ratio — 0.5% annually
Mid-range within the US Equities - Industry Sector category.
Effective Annual Expense Ratio (Net Expense Ratio)
평균권
0.5%
My positionMid-range
Low range Average High range
Actual Cost Simulation by Investment Amount
$100.0M
Annual Expense Ratio
$500K
Same as category average
Category Median Annual Cost
$500K
Based on expense ratio of 0.50%
10-Year Cumulative Expense Ratio (Long-term simulation assuming 7% annual market growth)
$9.0M
9.3% of returns you could have earned goes to the fund manager due to fees
💡 Because the expense ratio takes a slice of your assets every year, costs compound over 10 years and result in far greater losses than a simple sum (annual fee × 10). The 7% annual return assumption is based on the S&P 500's long-term average.

Defaults shown against $100K baseline portfolio. Adjust the slider to update the amount in real time.

Cheaper alternatives in the same category

* A lower fee does not necessarily mean a better ETF. Consider the tracked index, liquidity, and tax treatment as well.

Long-Term Performance

1-year · 3-year · 5-year · 10-year returns · vs. benchmark · drawdown defense

Average long-term returns
Near the US Equities - Industry Sector median.+76.2%p vs. benchmark (SPY) over 1Y.
ℹ️ The "1Y·3Y·5Y·10Y" periods below represent annualized returns (CAGR) measured backward from today. Example: "3Y +12%" means the investment grew at a compounded 12% per year over the past three years.
If you had invested 10 year(s) ago
$100.0M
Today's value
$294.9M
Total gain
+$194.9M
Annualized +11.4%
1 Year
2025.07 ~ 2026.07
Annualized +93.99%
상위 5%
Outperformed the benchmark by 76.2%p annually
My positionTop 5%
Low range Average High range
3 Years
2023.07 ~ 2026.07
Annualized +27.95% Cumulative +109.5%
상위 25%
Outperformed the benchmark by 8.7%p annually
My positionTop 25%
Low range Average High range
5 Years
2021.07 ~ 2026.07
Annualized +7.94% Cumulative +46.5%
평균권
Trailed the benchmark by 5.3%p annually
My positionMid-range
Low range Average High range
10Y
2016.07 ~ 2026.07
Annualized +11.42% Cumulative +194.9%
평균권
Trailed the benchmark by 3.5%p annually
My positionMid-range
Low range Average High range
10Y Cumulative Total Return Curve
2016-07-28 start, based on a 100M KRW base — read the curve values directly as units of 100M KRW (e.g., 308 → 3.08억 / 308M KRW). Both this ETF and the benchmark are rebased to 100 on the same start date for comparison.
SBIO · Price Only SBIO · Price + Cumulative Dividends SBIO · Dividend Reinvested S&P 500 (SPY)
50
150
250
350
450
ℹ️ Price Only: Excludes dividends and tracks pure stock price only. Covered-call and high-dividend ETFs often show a flat or declining line on this view, which is meaningful from a "principal preservation" standpoint. Price + Cumulative Dividend: Share count stays the same and received dividends are accumulated as cash. Closely matches your actual account total assets. Reinvested: Dividends are immediately used to buy additional shares (adjClose-based, the industry standard for total return). The wider the gap between the three lines, the easier it is to gauge the effectiveness of the dividend strategy.
Annual Return Comparison
ETF returns vs S&P 500 (SPY) by calendar year
SBIO S&P 500 (SPY)
+60%
0%
−60%
+44%
2017
-13%
2018
+48%
2019
+23%
2020
-18%
2021
-30%
2022
+11%
2023
+4%
2024
+54%
2025
+27%
2026 YTD
ℹ️ Returns from January 1 to December 31 of each year. The current year (2026) column is dimmed to indicate YTD (incomplete). If blue is higher than gray, the ETF outperformed the benchmark in that year.
Win rate vs S&P 500 (SPY)
4 / 9Y
Roughly even with benchmark (44%)
+ 2026 YTD: Ahead (26.6% vs 8.7%)
2017
2018
2019
2020
2021
2022
2023
2024
2025
2026 YTD
ℹ️ Number of winning years versus S&P 500 (SPY) within a completed calendar year (1/1–12/31). The current year (YTD) is reported separately.
Downside Capture
⚖️ 107%
Falls in line with the benchmark — high correlation
<85% (Defend) 85~110% (Track) >110% (Lag)
ℹ️ Average % drop of this ETF when S&P 500 (SPY) is −1%. Based on daily returns over the past 3 years (only days where the benchmark is negative).

Risk Profile

Volatility · Beta · Max Drawdown · Sharpe · Drawdown Recovery History

Overall Risk Grade
Moderate Risk
Volatility is around market average. Be prepared for losses of roughly -30% to -40% in major downturns.
Beta (market sensitivity)
평균권
0.75
If the market rises +10% +7.5%
If the market falls -10% -7.5%
My positionMid-range
Low range Average High range
ℹ️ A beta of 1.0 moves in line with the market. Above 1 means it moves more than the market; below 1 means less.
Average daily range (last 1 month)
하위 25%
±2.78%
S&P 500 typically ±1.0~1.3% · Bond funds ±0.3% · Leveraged ETFs ±3% or more
Annual volatility trend (past 10 years)
ℹ️ This ETF's average daily price swing. 1% means "on average, moves about ±1% per day." The rolling curve below shows the annualized volatility (long-term standard measure) over time.
Max Drawdown · Past 10 years
-63.1%
Drawdown duration: 33 months
2021-02-08 → 2023-10-27
Recovered in about 2.7 years
2015-07-31 Worst -61% 2026-07-01
ℹ️ Maximum drawdown is the largest peak-to-trough decline in the past. It represents the worst-case loss a long-term investor must psychologically endure.
Sharpe Ratio (Risk-Adjusted Return)
0.08
Weak — Low risk-adjusted returns
ℹ️ Annualized return minus the risk-free rate (3% annualized), divided by annualized volatility. A value above 1.0 is generally considered good risk-adjusted performance.
Estimated Monthly Maximum Loss (VaR 95%)
-13.9%
Historically, monthly losses exceeding this figure occurred only5%of the time.
ℹ️ A statistical estimate meaning "with 95% probability, monthly losses will not exceed this amount." The remaining 5% corresponds to crisis-level events such as financial crises or pandemics.

Overall investment appeal

What this ETF fits best — strengths, weaknesses, and target investor profile

Strengths and weaknesses both present Check the fit below to see whether it matches your investing goal.
🎯 목적별 적합도
내가 이 ETF를 어떤 목적으로 활용할 수 있는지 확인하세요.
🌳
장기 보유
수년 이상 꾸준히 모아갈 때
낮음
💵
배당 인컴
매월·분기 현금흐름이 목적일 때
매우 낮음
단기 트레이딩
며칠~몇 주 단기 방향성 매매
매우 낮음
🧩
포트폴리오 보조
자산 배분·헤지 용도
낮음
👤
이런 분에게 어울려요
Long-term and recurring investors
✅ 강점
뚜렷한 강점이 드러나지 않아요.
⚠️ 약점·주의사항
  • ⚠️Volatility is above average
  • 🎯Trails benchmark by -5.3%p annually

Portfolio Composition

What's actually inside — sector weights and top holdings

92개 종목에 넓게 분산
개별 종목 리스크가 분산되어 있어요.
ℹ️ 왜 구성을 봐야 하나요?
ETF의 실제 성과는 담고 있는 종목과 섹터에서 나와요. 이름이 "S&P 500"이라도 기술주 비중이 유난히 높을 수 있고, "배당주 ETF"라도 몇몇 대형주에 쏠려 있을 수 있어요. 라벨보다 실제 구성을 확인하는 게 중요해요.
🔬 집중도 한눈에 보기
총 보유종목
92개
상위 10개 비중
30.5%
최대 단일 종목
4.66%
집중도(HHI)
190
낮음 (분산)
🥧 섹터 비중
88%Healthcare
Healthcare
87.6%
📋 상위 보유 종목 Top 10 Top 10이 전체의 30.5% 차지
티커 옆의 점 색상 = 섹터 구분 (섹터 차트와 동일 색상)
#1 KYMR KYMR Kymera Therapeutics Inc
4.66%
#2 CELC CELC Celcuity Inc
3.34%
#3 ALKS ALKS Alkermes Plc
3.21%
#4 CGON CGON Cg Oncology Inc
3.06%
#5 MIRM MIRM Mirum Pharmaceuticals Inc
3.06%
#6 FOLD FOLD Amicus Therapeutics Inc
2.86%
#7 ACAD ACAD Acadia Pharmaceuticals Inc
2.68%
#8 NAMS NAMS Newamsterdam Pharma Co Nv
2.60%
#9 CRNX CRNX Crinetics Pharmaceuticals Inc
2.52%
#10 APGE APGE Apogee Therapeutics Inc
2.48%

Category Peers

Category: US Equities - Industry Sector

같은 카테고리 6종 중 AUM 6/6위 · 보수율 6/6위
카테고리: US Equities - Industry Sector
ℹ️ 왜 비교해야 하나요?
같은 카테고리 ETF끼리는 보수율·규모(AUM)·배당률을 비교해 볼 가치가 있어요. 보수율은 낮을수록 장기 수익에 유리하고, AUM이 크면 운용 안정성이 높아요. ▲ 표시SBIO보다 유리, ▼ 표시SBIO보다 불리를 뜻해요.
티커ETF명보수율AUM보유종목배당률YTD1년
SBIO SBIO
ALPS Medical Breakthroughs ETF0.5% $204M 107- +24.01% +91.77%
State Street Health Care Select Sector SPDR ETF0.08% $42.1B 631.51% - +23.63%
Vanguard Health Care ETF0.09% $18.4B 4281.51% - +25.59%
State Street SPDR S&P Biotech ETF0.35% $9.9B 1570.38% - +73.02%
iShares U.S. Healthcare ETF0.38% $3.4B 1051.14% - +23.51%
Fidelity MSCI Health Care Index ETF0.08% $3.3B 3221.26% - +26.05%
AUM 내림차순 정렬 · ▲ SBIO보다 유리 · ▼ SBIO보다 불리
📊
See the market at a glance with a real-time dashboard Track premarket, regular, and after-hours quotes, screeners, and heatmaps on a single screen

Leveraged & Covered Call ETFs on the Same Theme

ETFs that approach the same theme with a different strategy

6 ETFs tracking the same theme as SBIO using leveraged or covered call strategies (Leverage 4 · Inverse 1 · Covered Call 1)
Not direct derivatives of SBIO, but ETFs that cover the same theme via a different strategy.
ℹ️ Which ETFs are included?
Among ETFs whose theme (category or sector) overlaps with SBIO, some use special strategies. Leveraged ETFs aim for 2–3× the daily move, Inverse ETFs seek opposite-direction returns, and Covered Call ETFs generate monthly income from option premiums.
⚠️ Caution: Long-Term Holding
Leveraged and inverse ETFs track only the daily return. With high volatility, holding them for longer periods causes cumulative volatility decay—returns diverge further from the underlying index. They are meant for short-term trading.
🧺
Deeper Analysis at the ETF Center ETF overlap, sector exposure, and X-Ray analysis tools

FAQ

What kind of ETF is SBIO?

SBIO is an ETF in the US Equities - Industry Sector category, managed by ALPS.

How many holdings does SBIO have?

SBIO holds a total of 107 securities, with an AUM of approximately $204M.

What is the 52-week high and low for SBIO?

SBIO has recorded a 52-week high of $69.34 and a low of $32.35.

시황 · 실적발표 · 매수매도 신호, 가장 먼저 받아보세요 🔔 구독

면책조항: 본 콘텐츠는 참고 자료이며 투자 권유가 아닙니다. 모든 투자의 책임은 투자자 본인에게 있습니다.